Biohaven Ltd. BHVN
Regular-session close
After hours · Nov 20, 7:39 PM ET
- YTD
- +9.74%
- 1 year
- +28.66%
Held by funds
89 US ETFs and mutual funds hold BHVN · largest positions
- XBI 0.50% of fund $49.19M
- IWM 0.06% of fund $47.69M
- NJM 0.04% of fund $29.68M
- FBIOX 0.48% of fund $28.44M
- FSSNX 0.07% of fund $22.42M
- VXF 0.02% of fund $21.80M
- IWO 0.13% of fund $17.26M
- IBB 0.13% of fund $13.66M
- VTWO 0.07% of fund $12.11M
- NLO 0.07% of fund $10.52M
- SCHA 0.04% of fund $8.32M
- BDSKX 0.13% of fund $7.12M
- PINK 2.05% of fund $6.79M
- VSEQX 0.05% of fund $6.55M
- FSMAX 0.02% of fund $6.53M
- VEXRX 0.03% of fund $6.49M
- FESM 0.10% of fund $6.40M
- VHT 0.02% of fund $5.86M
- SHSSX 0.08% of fund $5.38M
- MDSKX 0.07% of fund $3.84M
Ownership
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 8.57% | 12,951,180 | 160.27M | Sep 29, 2026 |
| Montanova Capital LLC | 6.81% | 10,286,937 | 127.30M | Sep 29, 2026 |
| Stifel Financial Corporation | 6.58% | 9,941,685 | 123.03M | Sep 29, 2026 |
| Woodline Partners LP | 5.07% | 7,660,635 | 94.80M | Sep 29, 2026 |
| State Street Corporation | 4.55% | 6,874,721 | 85.07M | Sep 29, 2026 |
| Infinitum Asset Management, LLC | 4.14% | 6,250,000 | 77.34M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.45% | 3,699,312 | 45.78M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.29% | 3,455,073 | 42.76M | Sep 29, 2026 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 1.41% | 2,130,196 | 26.36M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.99% | 1,489,215 | 18.43M | Jun 29, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 0.97% | 1,468,076 | 18.17M | Aug 30, 2026 |
| iShares Trust-iShares Russell 2000 Growth ETF | 0.83% | 1,248,218 | 15.45M | Sep 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs BHVN, and what each was last paid
Vladimir Coric, Chairman & Chief Executive OfficerAverage age 57
| Name | Title | Pay | Age |
|---|---|---|---|
| Vladimir Coric | Chairman & Chief Executive Officer | $1.40M | 55 |
| Matthew Buten | Chief Financial Officer | $859K | 65 |
| Bruce D. Car DACVP | Chief Innovation Officer | $801K | 64 |
| Kimberly Gentile | Senior Vice President of Clinical Operations | $758K | 60 |
| Jennifer Porcelli | Vice President of Investor Relations | — | — |
| Warren Volles | General Counsel & Chief Legal Officer | — | — |
| Deb Young | Senior Director of Regulatory Affairs & Operations | — | — |
| Clifford Bechtold | President, GM of Biohaven Ireland & Chief Compliance Officer | — | — |
| George C. Clark | Vice President & Chief Accounting Officer | — | 41 |
| John McGill | Chief Technology Officer | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAILEY GREGORY HUGH | Director | Purchase | Nov 12, 2025 | 2,020,070 |
| BUTEN MATTHEW | Chief Financial Officer | Conversion of Exercise of derivative security | Jan 4, 2026 | 195,652 |
| CAR BRUCE | Officer | Conversion of Exercise of derivative security | Jan 4, 2026 | 37,715 |
| CHILDS JOHN W | Director | Purchase | Nov 12, 2025 | 0 |
| CLARK GEORGE C. | Officer | Conversion of Exercise of derivative security | Jan 4, 2026 | 86,978 |
| CORIC VLADIMIR | Chief Executive Officer | Conversion of Exercise of derivative security | Jan 4, 2026 | 3,849,350 |
